[1] |
LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng.
Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
|
[2] |
HOU Nan, LIU Yuan, GAO Jun, WANG Jing, YUAN Meng.
Whole blood NPM1, MCP-1 and intestinal flora are associated with gastric cancer progression and prognosis
[J]. Basic & Clinical Medicine, 2024, 44(8): 1137-1142.
|
[3] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
[4] |
SONG Lili, GUAN Yujie, MA Ping, LI Ning.
Association between daunorubicin resistance and PD-L1 protein expression in children with acute myeloid leukemia
[J]. Basic & Clinical Medicine, 2024, 44(6): 833-839.
|
[5] |
CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng.
Correlation between circulating CD4+CD45RA+CD62L+ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI
[J]. Basic & Clinical Medicine, 2024, 44(5): 658-664.
|
[6] |
LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang.
Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis
[J]. Basic & Clinical Medicine, 2024, 44(4): 503-512.
|
[7] |
YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie.
Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells
[J]. Basic & Clinical Medicine, 2024, 44(4): 467-473.
|
[8] |
ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin.
Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib
[J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
|
[9] |
LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai.
Efficacy of cinobufacini capsule combined with docetaxel plus cisplatin chemotherapy for the treatment of non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2024, 44(2): 247-251.
|
[10] |
DING Fei, WANG Sa, HUANG Changxin.
Serum CA211 level and NK cell number are associated with prognosis of patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2024, 44(2): 180-184.
|
[11] |
.
Association of seven antibody levels in lung cancer with chemotherapy effect and prognosis in patients with NSCLC
[J]. Basic & Clinical Medicine, 2024, 44(10): 1383-1387.
|
[12] |
.
Clinical characteristics and prognosis of acute B-lymphoblastic leukemia complicated with chemotherapy-induced peripheral neuropathy in children
[J]. Basic & Clinical Medicine, 2024, 44(10): 1394-1399.
|
[13] |
Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing.
Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.
|
[14] |
GONG Ziqi, WU Xiaowen, GUO Qian, GUO Jun, KONG Yan.
Influence of PTEN mutation on pathological features and prognosis of patients with mucosal melanoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1341-1345.
|
[15] |
YAN Chenhong, JIN Er.
Progress of exosomal PD-L1 in diagnosis and treatment of non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2023, 43(9): 1457-1461.
|